Table 6.
Fayoumi GO Term | Count | P-valuea |
FN3 | 22 | 1.10E-03 |
Ribonucleotide binding | 154 | 1.70E-03 |
Purine ribonucleotide binding | 154 | 1.70E-03 |
Fibronectin, type III | 22 | 8.10E-03 |
PTPc | 8 | 1.70E-02 |
Nucleotide binding | 177 | 2.10E-02 |
Protein kinase activity | 61 | 2.60E-02 |
Leghorn GO Term | Count | P-valuea |
ECM-receptor interaction | 25 | 9.60E-05 |
Extracellular matrix | 41 | 1.90E-04 |
Metal ion binding | 270 | 2.30E-03 |
Proteinaceous extracellular matrix | 37 | 1.30E-03 |
Extracellular region | 94 | 2.30E-03 |
Cell division and chromosome partitioning | 26 | 2.60E-02 |
Calcium ion binding | 77 | 3.90E-02 |
Aminophospholipid transporter activity | 7 | 4.30E-02 |
Phospholipid-translocating atpase activity | 7 | 4.30E-02 |
Over-represented GO terms for moderate impact variants (fixed/segregating) and unique for the inbred Fayoumi and Leghorn lines. aBenjamini-Hochberg Corrected p-value cut-off α = 0.05. bModerate impact variants: non_synonymous_coding, codon_change, codon_insertion, codon_change_plus_codon_insertion, codon_deletion, codon_change_plus_codon_deletion, utr_5_deleted, utr_3_deleted